Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€495.80

€495.80

0.280%
1.4
0.280%
€523.82

€523.82

 
08:16 / Tradegate WKN: 893953 / Symbol: MCK / Name: McKesson / Stock / Food & Drug Retailing / Large Cap /
Latest predictions
€579.76
30.04.24
-1.55%
buy
€515.34
15.04.24
0.75%
buy
€531.01
10.04.24
0.49%
buy
€550.00
31.03.24
-0.84%
buy
€568.42
06.03.24
2.23%
buy
27.02.24
2.98%
buy
Best running prediction
€449.81
07.08.23
29.90%
buy
Your prediction

McKesson Corp. Stock

The McKesson Corp. stock is trending slightly upwards today, with an increase of €1.40 (0.280%) compared to yesterday's price.
With 16 Buy predictions and not the single Sell prediction the community is currently very high on McKesson Corp..
With a target price of 523 € there is a slightly positive potential of 5.49% for McKesson Corp. compared to the current price of 495.8 €.

Pros and Cons of McKesson Corp. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of McKesson Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
McKesson Corp. 0.280% -1.749% -0.222% 50.274% 19.420% 216.923% 363.529%
Cardinal Health Inc. 0.920% -0.785% -7.047% 28.266% 6.689% 91.351% 122.733%
CVS Health Corp. 0.600% -18.069% -25.000% -22.185% -28.224% -19.100% 1.580%
AmerisourceBergen Corp. -0.450% -6.240% -7.174% 35.611% 13.938% 107.525% 213.913%

Comments

Prediction Buy
Perf. (%) -1.55%
Target price 579.762
Change
Ends at 30.04.25

McKesson Co. (NYSE: MCK) had its price target raised by analysts at Citigroup Inc. from $575.00 to $620.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.75%
Target price 515.339
Change
Ends at 15.04.25

McKesson Co. (NYSE: MCK) had its price target raised by analysts at Morgan Stanley from $522.00 to $548.00. They now have an "overweight" rating on the stock.
Ratings data for MCK provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.49%
Target price 531.012
Change
Ends at 10.04.25

McKesson Co. (NYSE: MCK) had its price target raised by analysts at Argus from $510.00 to $570.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
Show more

News

McKesson (MCK) Q3 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
McKesson (MCK) Q3 2024 Earnings Call Transcript

Image source: The Motley Fool.

McKesson (NYSE: MCK)Q3 2024 Earnings CallFeb 07, 2024, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks: https://g.foolcdn.com/editorial/images/756811/medical-staff-talk-with-management.jpg
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks

Bigtime medical distributors like McKesson (NYSE: MCK) and Cencora (NYSE: COR) make money by moving drugs and supplies to clinics and pharmacies worldwide. While investors usually look to such